Patent Expiry
Patent/Exclusivity Expiry: HALAVEN
- Drug
- HALAVEN
Other upcoming events for JAZZ
Phase 3 ReadoutPhase 3 Topline: A Phase III, Randomized, Open-Label, Multicenter Study of Lurbinectedin in Combination With Atezoliz
Phase 2 StartPhase 2 Start: A Pilot Study, Open-Label Study of ONC201 for Refractory Meningioma
Phase 2 StartPhase 2 Start: A Phase IIb Study of the Safety and Efficacy of Nabiximols in Subjects With Spasticity Due to Neurom
Phase 3 ReadoutPhase 3 Topline: Randomized Phase III Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX
Phase 3 ReadoutPhase 3 Topline: A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination With Chemotherapy With or Wit
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.